n.1.(Physiol.) A complex nitrogenous substance, which, by Hermann's hypothesis, is continually decomposed and reproduced in the muscles, during their life.
Webster's Revised Unabridged Dictionary, published 1913 by G. & C. Merriam Co.
References in periodicals archive ?
(U.S.), Chart Industries (U.S.), ACare Technology (Taiwan), Dragerwerk AG (U.S.), Fisher & Paykel Healthcare (New Zealand), GE Healthcare (U.K), Inogen (U.S.), Koninklijke Philips N.V (the Netherlands) are some of the prominent players at the forefront of competition in the Global Respiratory Therapeutic Devices Market and are profiled in MRFR Analysis.
* Stifel Nicolaus cut the price target for Inogen Inc(NASDAQ: INGN) from $85 to $48.
As previously reported, SVB Leerink analyst Danielle Antalffy downgraded Inogen to Market Perform from Outperform and lowered her price target on the shares to $47 from $78.
One month later, the patient was re-admitted, and a Boston Scientific Inogen X4 CRT-D was implanted under general anesthesia as requested by the manufacturing company to avoid any possible dislodgement of the previously deployed device.
She was prescribed an oxygen concentrator and ended up with the Inogen One G3.
David Smith, Inogen Carter and Ally Carnwath in their respective articles have emphasized on the notion of positivism enveloped in an atmosphere of despair and hopelessness as presented by Samuel Beckett in his play Waiting for Godot.
Medical company Inogen (Nasdaq:INGN) said on Tuesday that its board of directors has elected Scott Wilkinson as its president and chief executive officer with effect from 1 March 2017 as well as a member of its board of directors from 1 January 2017.
According to the company, the all high-voltage products currently marketed in Europe include AUTOGEN, DYNAGEN, INOGEN and ORIGEN devices as well as ACUITY X4 quadripolar LV leads, INGEVITY and FINELINE II pacing leads and RELIANCE 4-SITE and 4-FRONT defibrillator.
* The FDA approved Boston Scientific's latest generation of defibrillators and heart failure devices, including the Dynagen Mini and Inogen Mini ICDs, as well as the Dynagen X4 and Inogen X4 CRT-Ds.
Inogen Inc, a medical technology company, has entered into a partnership with JPMorgan Chase & Co (NYSE: JPM).